Evaluating mono and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the Hollow-Fiber Infection Model
M. L. Avent, K. L. McCarthy, F. Sime, s. naicker, A. J. Heffernan, S. Wallis, D. Paterson, J. A. Roberts
This study evaluates the effectiveness of meropenem and amikacin as monotherapy and combination therapy against Pseudomonas aeruginosa isolates using a hollow-fiber infection model, finding improved bacterial killing with combination therapy.
bioRxiv · Dec 23, 2021Pharmacology & Toxicology